Article

<i>Ex Vivo</i> Validation of Six FDA-Approved Non-Receptor Tyrosine Kinase Inhibitors (NRTKIs) as Antivirals to Pandemic and Seasonal Influenza A Viruses

2022-01-20

Abstract excerpt

<h4>ABSTRACT</h4> Influenza viruses are important respiratory pathogens that cause substantial morbidity and mortality annually. In addition to seasonal influenza outbreaks, new emerging influenza A viruses (IAV) can cause pandemic influenza outbreaks. Apart from effective vaccines, there is a need for better treatment options to combat infections with these viruses when vaccines are not available or show reduced...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 311614e9-8cbc-5ad0-ade8-cedcb22a9376
DOI: 10.1101/2022.01.19.476993

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

<i>Ex Vivo</i> Validation of Six FDA-Approved Non-Receptor Tyrosine Kinase Inhibitors (NRTKIs) as Antivirals to Pandemic and Seasonal Influenza A VirusesDOI 10.1101/2022.01.19.476993Read

Identification of Novel and Efficacious Chemical Compounds that Disturb Influenza A Virus Entry in vitroSemantic proximity Read

Cellular targets for influenza drugsSemantic proximity Read

4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza virusesSemantic proximity Read

Global Human-Kinase Screening Identifies Therapeutic Host Targets against InfluenzaSemantic proximity Read

New treatments for influenzaSemantic proximity Read

Special Issue “Host Targeted Therapeutics Against Virus Infections”Semantic proximity Read

Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA VirusesSemantic proximity Read

A small molecule RIG-I agonist serves to adjuvant broad multifaceted influenza virus vaccine immunitySemantic proximity Read

Antiviral activity of influenza A virus defective interfering particles against SARS-CoV-2 replication <i>in vitro</i> through stimulation of innate immunitySemantic proximity Read

Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.Semantic proximity Read

Proteomic and genetic analyses of influenza A viruses identify pan-viral host targetsSemantic proximity Read

The Screening and Mechanism of Influenza-Virus Sensitive MDCK Cell Lines for Influenza Vaccine ProductionSemantic proximity Read